Repeatability of AO-SLO (Mona IIa) Technology and Cone Cell Density of Individuals Use Repeated Low-level Red-light Therapy
- Sponsor
- Ruihua Wei
- Study ID
- NCT07160036
- Status
- Recruiting
Conditions
- Myopia
Eligibility Criteria
- Sex
- ALL
- Age
- 6 Years - 55 Years
- Healthy Volunteers
- Not accepted
Interventions
- RLRL(Model RS-200-2A, Eyerising; Suzhou Xuanjia Optoelectronic Technology Co., Ltd., Suzhou, China)) — DEVICEuse RLRL twice a day
Study Details
To explore the repeatability of AO-SLO (Mona IIa) technology and the difference of cone cell density between individuals who used or not used repeated low-intensity red light treatment
Key Dates
- First listed
- Sep 8, 2025
- Start date
- Sep 20, 2025
- Status verified
- Sep 2025
- Primary completion
- Nov 20, 2025
- Completion
- Dec 20, 2025
Study Design
- Enrollment
- 180 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: RLRL groupUse RLRL (Model RS-200-2A, Eyerising; Suzhou Xuanjia Optoelectronic Technology Co., Ltd., Suzhou, China)
- No Intervention: No RLRL GroupNo use RLRL
Primary Outcome Measure
The density of cone cells [ Time Frame: From enrollment to the end of treatment at 3 weeks ]
Central Contacts
- Guihua Liu+8686428756
Related Studies
- Diagnostic Innovations in Glaucoma StudyRecruiting · University of California, San Diego · La Jolla, California
- Clinical Applications of Advanced Ophthalmic ImagingRecruiting · University of Miami · Miami, Florida
- Contoura With Phorcides Compared to Wavefront Optimized LASIKRecruiting · Daniel Terveen · Bozeman, Montana
- Axial Length With Adult Onset Myopia (ALWAOM)Enrolling By Invitation · Art Optical Contact Lens, Inc. · St Louis, Missouri